Deblistering Machines Market: Expected to Reach US$ 270.0 Million by 2033, Driven by Rising Demand for Pharmaceutical

According to analysts at Future Market Insights (FMI), the deblistering machines market is poised for growth in 2023, expected to surpass a valuation of US$ 165.0 million. Projections indicate a notable uptrend, with the market's value projected to witness a 5.0% increase between 2023 and 2033, reaching an anticipated valuation of US$ 270.0 million by 2033. This growth trajectory underscores the rising demand for efficient pharmaceutical packaging processes. As the market embraces advancements in deblistering technology, the anticipated CAGR of 5.0% signifies sustained industry expansion, reflecting the sector's adaptability to evolving pharmaceutical packaging requirements. The demand for highly efficient deblistering machines for the secure and safe removal of tablets and capsules from blister packs has witnessed significant growth in the last few years and is projected to continue experiencing astonishing demand during the forecast period.

At the conclusion of the analytical timeframe, the Indian deblistering machines market is anticipated to showcase a robust Compound Annual Growth Rate (CAGR) of 7.2%. Projections suggest that the market size will ascend to US$ 13.3 million in 2023, doubling to US$ 26.4 million by the study period’s conclusion. India, as a prominent player in the global pharmaceutical landscape, maintains a crucial role by serving as a major producer of both generic and branded medicinal drugs. The country’s continuous contributions to pharmaceutical production underscore its significance in meeting the global demand for pharmaceuticals on a substantial scale.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6645

Research-based German pharmaceutical industry is more inclined towards the launch of new medicinal drugs and extension of product pipelines. Strong capital investment in drug development in Germany is redefining the pharmaceutical market’s growth in the country.

As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the capital invested in research and development in German Pharmaceutical Industry was US$ 9,440 million in 2019, which is the highest among the other European countries.

Business Growth Drivers:

1. Increasing Pharmaceutical Production: The growing demand for pharmaceuticals globally is driving the need for efficient packaging solutions, including deblistering machines, to handle blister packs efficiently.

2. Rising Need for Drug Repackaging: As the pharmaceutical industry expands, there's a parallel need for drug repackaging due to factors such as regulatory changes, expiration dates, or patient-specific packaging requirements. Deblistering machines facilitate this process by safely removing pills or tablets from blister packs for repackaging.

3. Focus on Automation and Efficiency: Pharmaceutical manufacturers are increasingly adopting automation to improve production efficiency and reduce labor costs. Deblistering machines play a crucial role in this trend by automating the process of removing medications from blister packs, thereby streamlining operations.

4. Stringent Regulatory Requirements: Regulatory bodies such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency) often mandate strict guidelines for pharmaceutical packaging and repackaging. This drives the adoption of advanced deblistering machines that ensure compliance with regulatory standards.

5. Technological Advancements: Continuous technological advancements in deblistering machines lead to improved efficiency, accuracy, and versatility, further fueling market growth. Features like adjustable speed, precision handling of different blister pack sizes, and integration with other packaging machinery enhance the appeal of these systems.

6. Growing Pharmaceutical Waste Concerns: With increasing environmental awareness, there's a heightened focus on reducing pharmaceutical waste generated during packaging and repackaging processes. Deblistering machines help minimize waste by salvaging intact medications from blister packs, aligning with sustainability goals.

Industry Restraints:

1. High Initial Investment: Acquiring and installing deblistering machines can involve significant upfront costs, which may deter small or medium-sized pharmaceutical companies from investing in these systems.

2. Complexity of Operations: Deblistering machines require specialized training for operation and maintenance. The complexity of these machines may pose a challenge for some companies, especially those with limited technical expertise or resources.

3. Compatibility Issues: Ensuring compatibility between deblistering machines and various types of blister packs can be challenging. Some machines may struggle to handle certain blister materials or pack configurations, limiting their applicability across different products.

4. Risk of Product Damage: Improper handling during the deblistering process can lead to product damage, compromising the integrity of medications and potentially causing losses for pharmaceutical manufacturers. Mitigating this risk requires careful calibration and monitoring of machine settings.

5. Market Fragmentation: The deblistering machines market is relatively fragmented, with numerous players offering a wide range of products with varying features and quality levels. This can make it difficult for buyers to navigate and select the most suitable solution for their needs.

6. Regulatory Compliance Challenges: Adhering to evolving regulatory requirements pertaining to pharmaceutical packaging and repackaging poses ongoing challenges for manufacturers and suppliers of deblistering machines. Compliance issues can result in delays, fines, or even product recalls, impacting market dynamics.

Key Takeaways from Deblistering Machines Market

• Automatic deblistering machines are projected account for more than 70% of the overall market share driven by higher operational speed.
• 40 to 80 BPM machines will remain dominant in the market, while the over 80 BPM machines are estimated to reflect faster growth with an incremental opportunity of US$ ~ 24.3 Mn.
• With the frequent use of deblistering machines in the pharma sector, the U.S. market is expected to expand by more than1.5 times.
• Manufacturers are capitalizing on opportunities across lucrative markets such as India and China.
• Expansion of healthcare sector will spur y-o-y growth in the U.K. at 2.8% in 2021.

The rise in production of medicinal drugs, especially those requiring oral dosages such as tablets and capsules has created lucrative opportunities for deblistering machine manufacturers to maximize their sales. Rising emphasis on safe and secure removal of medicinal tablets and capsules with high-precision deblistering processes is anticipated to redefine the market growth,” says FMI analyst.

Deblistering Machines Market Landscape

• Omnicell, Inc,
• Uhlmann Pac-Systeme GmbH & Co. KG,
• ACG Worldwide Private Limited

are the top players operating in the deblistering machines market. Furthermore,

• RBP Bauer GmbH,
• Jornen Machinery Co., Ltd,
• Sepha Limited,
• Stripfoil Deblistering Technology,
• Elmach Packages India Pvt. Ltd

are also the noticeable players in the deblistering machines market.

The Tier 3 players in the market hold 65-70% in the global deblistering machines market. In conclusion, key players contribute almost 30-35% of the global market. Leading players in the industry are increasingly focused on investments into product development to expand portfolios, consolidating overall market position.

Recent Development

Considering the current need from the pharmaceutical sector, leading packaging machinery manufacturers are offering deblistering machinery with next-level automation. Manufacturers operating in the global deblistering machines market are designing, manufacturing, and offering deblistering machines that are suitable for end-users. This can be exemplified by

• Stripfoil Deblistering Technology’s deblistering machine, which has a fully automated deblistering operation coupled with an operating speed of 80 to 140 blisters per minute. The same deblistering machines are capable of deblistering almost all types of blister formats.
• SEPHA, manufacturer of deblistering machines, has designed deblistering machines with features such as automatic feed and user interface with fault indicators, easy tooling changeover, variable speed of up to 60 blisters per minute, and others. The demand for such end-use industry-oriented deblistering machines is propelling in the market, owing to its innovative features, which further reinforces the market growth.

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/6645

Key Segments Covered in Deblistering Machines Industry Research

Automation:

• Automatic
• Semi-Automatic
• Manual

Operating Speed:

• Up to 40 BPM
• 40 to 80 BPM
• Above 80 BPM

End Use:

• Pharmaceutical Manufacturers
• Pharmacies
• Hospitals & Clinical Laboratories
• Medical Waste Recyclers
• Contract Manufacturers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube